SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Heska Corporation (HSKA) .
Criteria proven by this page:
- VALUE (90/100, Pass) — analyst target implies upside (+32.9%).
- Analyst consensus target $159.50 (+32.9% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 53/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
90/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HSKA
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio4.82
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.78
Book Value / Share$0.00
Revenue / Share$24.88
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$159.50 (+32.9%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2013 |
$-0.21 |
$78.34M |
$-1.2M |
-1.5% |
| 2014 |
$0.41 |
$89.84M |
$2.6M |
2.9% |
| 2015 |
$0.74 |
$104.6M |
$5.24M |
5% |
| 2016 |
$1.43 |
$130.08M |
$10.51M |
8.1% |
| 2017 |
$1.30 |
$129.34M |
$9.95M |
7.7% |
| 2018 |
$0.74 |
$127.45M |
$5.85M |
4.6% |
| 2019 |
$-0.15 |
$122.66M |
$-1.14M |
-0.9% |
| 2020 |
$-1.62 |
$197.32M |
$-14.03M |
-7.1% |
| 2021 |
$0.01 |
$253.74M |
$132K |
0.1% |
| 2022 |
$-1.78 |
$257.31M |
$-18.42M |
-7.2% |
